Neurosciences
Showing 726 - 750 of 814
Alzheimer's Disease Trial in Montpellier cedex (Experimental 1, Placebo Comparator)
Completed
- Alzheimer's Disease
- Experimental 1
- Placebo Comparator
-
Montpellier cedex, FranceCHU Gui de Chauliac
Jul 11, 2014
Glioblastoma, Anaplastic Astrocytoma Trial in Worldwide (drug, device, procedure)
Completed
- Glioblastoma
- Anaplastic Astrocytoma
- AP 12009 10 µM
- +4 more
-
Innsbruck, Austria
- +35 more
Dec 2, 2013
Bipolar Depression Trial in Worldwide (lurasidone, Placebo)
Convulsion, Non-Epileptic, Conversion Disorder, Depression Trial in Providence (sertraline, )
Completed
- Convulsion, Non-Epileptic
- +3 more
- sertraline
- placebo
-
Providence, Rhode IslandRhode Island Hospital
Nov 7, 2014
Bipolar Depression Trial in Worldwide (lurasidone + (lithium or divalproex), Placebo + (lithium or divalproex))
Completed
- Bipolar Depression
- lurasidone + (lithium or divalproex)
- Placebo + (lithium or divalproex)
-
Little Rock, Arkansas
- +70 more
Mar 31, 2014
Parkinson Disease Trial in Worldwide (1. Tesofensine (NS 2330))
Completed
- Parkinson Disease
- 1. Tesofensine (NS 2330)
-
Graz, Austria
- +49 more
Oct 28, 2013
Degenerative Cervical Disc Disease Trial in United States (Allograft Fusion and ATLANTIS™ Cervical Plate System, PRESTIGE®
Completed
- Degenerative Cervical Disc Disease
- Allograft Fusion and ATLANTIS™ Cervical Plate System
- PRESTIGE® Cervical Disc
-
Huntsville, Alabama
- +30 more
Jul 31, 2013
Stroke Trial in Worldwide (IV rt-PA alone, endovascular therapy)
Terminated
- Stroke
- IV rt-PA alone
- endovascular therapy
-
Birmingham, Alabama
- +70 more
Nov 19, 2013
Alzheimer's Disease Trial in United States (Bapineuzumab 0.5 mg/kg, Placebo Control, Bapineuzumab 1.0 m/kg)
Completed
- Alzheimer's Disease
- Bapineuzumab 0.5 mg/kg
- +2 more
-
Birmingham, Alabama
- +185 more
Oct 30, 2013
Multiple Sclerosis Trial in United States (Dalfampridine-ER 5mg, Dalfampridine-ER 10mg, Placebo)
Completed
- Multiple Sclerosis
- Dalfampridine-ER 5mg
- +2 more
-
Cullman, Alabama
- +69 more
Sep 3, 2013
Osteoarthritis, Chronic Pain Trial in United States (ALO-01 (Morphine Sulfate Plus Naltrexone Hydrochloride Extended Release),
Completed
- Osteoarthritis
- Chronic Pain
- ALO-01 (Morphine Sulfate Plus Naltrexone Hydrochloride Extended Release)
- Placebo
-
Birmingham, Alabama
- +80 more
Sep 13, 2013
Alzheimer's Disease Trial in Worldwide (Bapineuzumab 0.5 mg/kg, Placebo Control, Bapineuzumab 1.0 m/kg)
Completed
- Alzheimer's Disease
- Bapineuzumab 0.5 mg/kg
- +2 more
-
Birmingham, Alabama
- +250 more
Oct 30, 2013
Postpoliomyelitis Syndrome Trial in Dublin (Upper Limb Ergometry)
Completed
- Postpoliomyelitis Syndrome
- Upper Limb Ergometry
-
Dublin, IrelandBeaumont Hospital
Sep 18, 2013
Parkinson's Disease Trial in Serbia, United Kingdom (VR040/Aspirair® inhaler, )
Completed
- Parkinson's Disease
- VR040/Aspirair® inhaler
- placebo
-
Belgrade, Serbia
- +8 more
Sep 25, 2012
Schizophrenia Trial in Decatur (fMRI, Aripiprazole)
Schizophrenia, Schizoaffective Disorder Trial in Bangalore (D-serine, Cognitive retraining)
Completed
- Schizophrenia
- Schizoaffective Disorder
- D-serine
- Cognitive retraining
-
Bangalore, Karnataka, IndiaNational Institute of Mental Health and Neurosciences
Jun 15, 2012